The global Radiofrequency Ablation for Knee Osteoarthritis (OA) market is projected to grow from US$ 489 million in 2024 to US$ 1792 million by 2031, at a CAGR of 20.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Radiofrequency Ablation for Knee Osteoarthritis (OA) Market

RFA is a minimally invasive medical procedure used to alleviate chronic knee pain caused by osteoarthritis. It works by using heat generated from radiofrequency energy to target and deactivate specific sensory nerves responsible for transmitting pain signals from the knee to the brain.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Radiofrequency Ablation for Knee Osteoarthritis (OA) leading manufacturers including Boston Scientific, Stryker, Abbott, Avanos Medical (coolief), Cosman Medical, Diros Technology, Vantage MedTech, STARmed America, Beijing Neo Science, etc., dominate supply; the top five capture approximately % of global revenue, with Boston Scientific leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Radiofrequency Ablation for Knee Osteoarthritis (OA) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Report

Report Metric	Details
Report Name	Radiofrequency Ablation for Knee Osteoarthritis (OA) Market
Accounted market size in 2024	US$ 489 million
Forecasted market size in 2031	US$ 1792 million
CAGR	20.7%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Device Service
Segment by Application	Hospital Clinic
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boston Scientific, Stryker, Abbott, Avanos Medical (coolief), Cosman Medical, Diros Technology, Vantage MedTech, STARmed America, Beijing Neo Science
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Radiofrequency Ablation for Knee Osteoarthritis (OA) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Radiofrequency Ablation for Knee Osteoarthritis (OA) Market growing?

Ans: The Radiofrequency Ablation for Knee Osteoarthritis (OA) Market witnessing a CAGR of 20.7% during the forecast period 2025-2031.

What is the Radiofrequency Ablation for Knee Osteoarthritis (OA) Market size in 2031?

Ans: The Radiofrequency Ablation for Knee Osteoarthritis (OA) Market size in 2031 will be US$ 1792 million.

Who are the main players in the Radiofrequency Ablation for Knee Osteoarthritis (OA) Market report?

Ans: The main players in the Radiofrequency Ablation for Knee Osteoarthritis (OA) Market are Boston Scientific, Stryker, Abbott, Avanos Medical (coolief), Cosman Medical, Diros Technology, Vantage MedTech, STARmed America, Beijing Neo Science

What are the Application segmentation covered in the Radiofrequency Ablation for Knee Osteoarthritis (OA) Market report?

Ans: The Applications covered in the Radiofrequency Ablation for Knee Osteoarthritis (OA) Market report are Hospital, Clinic

What are the Type segmentation covered in the Radiofrequency Ablation for Knee Osteoarthritis (OA) Market report?

Ans: The Types covered in the Radiofrequency Ablation for Knee Osteoarthritis (OA) Market report are Device, Service

1 Study Coverage

1.1 Introduction to Radiofrequency Ablation for Knee Osteoarthritis (OA): Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Device

1.2.3 Service

1.3 Market Segmentation by Application

1.3.1 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Estimates and Forecasts 2020-2031

2.2 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Estimates and Forecasts 2020-2031

2.4 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Device Market Size by Manufacturers

3.5.2 Service Market Size by Manufacturers

3.6 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Type (2020-2031)

6.4 North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Type (2020-2031)

7.4 Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Type (2020-2031)

9.4 Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Boston Scientific

11.1.1 Boston Scientific Corporation Information

11.1.2 Boston Scientific Business Overview

11.1.3 Boston Scientific Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.1.4 Boston Scientific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Boston Scientific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Product in 2024

11.1.6 Boston Scientific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application in 2024

11.1.7 Boston Scientific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Geographic Area in 2024

11.1.8 Boston Scientific Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

11.1.9 Boston Scientific Recent Developments

11.2 Stryker

11.2.1 Stryker Corporation Information

11.2.2 Stryker Business Overview

11.2.3 Stryker Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.2.4 Stryker Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Stryker Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Product in 2024

11.2.6 Stryker Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application in 2024

11.2.7 Stryker Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Geographic Area in 2024

11.2.8 Stryker Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

11.2.9 Stryker Recent Developments

11.3 Abbott

11.3.1 Abbott Corporation Information

11.3.2 Abbott Business Overview

11.3.3 Abbott Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.3.4 Abbott Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Abbott Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Product in 2024

11.3.6 Abbott Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application in 2024

11.3.7 Abbott Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Geographic Area in 2024

11.3.8 Abbott Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

11.3.9 Abbott Recent Developments

11.4 Avanos Medical (coolief)

11.4.1 Avanos Medical (coolief) Corporation Information

11.4.2 Avanos Medical (coolief) Business Overview

11.4.3 Avanos Medical (coolief) Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.4.4 Avanos Medical (coolief) Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Avanos Medical (coolief) Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Product in 2024

11.4.6 Avanos Medical (coolief) Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application in 2024

11.4.7 Avanos Medical (coolief) Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Geographic Area in 2024

11.4.8 Avanos Medical (coolief) Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

11.4.9 Avanos Medical (coolief) Recent Developments

11.5 Cosman Medical

11.5.1 Cosman Medical Corporation Information

11.5.2 Cosman Medical Business Overview

11.5.3 Cosman Medical Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.5.4 Cosman Medical Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Cosman Medical Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Product in 2024

11.5.6 Cosman Medical Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application in 2024

11.5.7 Cosman Medical Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Geographic Area in 2024

11.5.8 Cosman Medical Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

11.5.9 Cosman Medical Recent Developments

11.6 Diros Technology

11.6.1 Diros Technology Corporation Information

11.6.2 Diros Technology Business Overview

11.6.3 Diros Technology Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.6.4 Diros Technology Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Diros Technology Recent Developments

11.7 Vantage MedTech

11.7.1 Vantage MedTech Corporation Information

11.7.2 Vantage MedTech Business Overview

11.7.3 Vantage MedTech Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.7.4 Vantage MedTech Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Vantage MedTech Recent Developments

11.8 STARmed America

11.8.1 STARmed America Corporation Information

11.8.2 STARmed America Business Overview

11.8.3 STARmed America Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.8.4 STARmed America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 STARmed America Recent Developments

11.9 Beijing Neo Science

11.9.1 Beijing Neo Science Corporation Information

11.9.2 Beijing Neo Science Business Overview

11.9.3 Beijing Neo Science Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Models, Descriptions and Specifications

11.9.4 Beijing Neo Science Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Beijing Neo Science Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Radiofrequency Ablation for Knee Osteoarthritis (OA) Industry Chain

12.2 Radiofrequency Ablation for Knee Osteoarthritis (OA) Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Radiofrequency Ablation for Knee Osteoarthritis (OA) Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Avanos Medical (coolief)

List of Tables

Table 1. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)

Table 7. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Region (2020-2025) & (Units)

Table 8. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Region (2026-2031) & (Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Manufacturers (2020-2025) & (Units)

Table 11. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Share by Manufacturers (2020-2025)

Table 12. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiofrequency Ablation for Knee Osteoarthritis (OA) as of 2024)

Table 16. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Radiofrequency Ablation for Knee Osteoarthritis (OA) Manufacturing Base and Headquarters

Table 19. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Type (2020-2025) & (Units)

Table 23. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Type (2026-2031) & (Units)

Table 24. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application (2020-2025) & (Units)

Table 29. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales by Application (2026-2031) & (Units)

Table 30. Radiofrequency Ablation for Knee Osteoarthritis (OA) High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Growth Accelerators and Market Barriers

Table 37. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Growth Accelerators and Market Barriers

Table 40. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Growth Accelerators and Market Barriers

Table 45. Southeast Asia Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Investment Opportunities and Key Challenges

Table 47. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Boston Scientific Corporation Information

Table 51. Boston Scientific Description and Major Businesses

Table 52. Boston Scientific Product Models, Descriptions and Specifications

Table 53. Boston Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Boston Scientific Sales Value Proportion by Product in 2024

Table 55. Boston Scientific Sales Value Proportion by Application in 2024

Table 56. Boston Scientific Sales Value Proportion by Geographic Area in 2024

Table 57. Boston Scientific Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

Table 58. Boston Scientific Recent Developments

Table 59. Stryker Corporation Information

Table 60. Stryker Description and Major Businesses

Table 61. Stryker Product Models, Descriptions and Specifications

Table 62. Stryker Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Stryker Sales Value Proportion by Product in 2024

Table 64. Stryker Sales Value Proportion by Application in 2024

Table 65. Stryker Sales Value Proportion by Geographic Area in 2024

Table 66. Stryker Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

Table 67. Stryker Recent Developments

Table 68. Abbott Corporation Information

Table 69. Abbott Description and Major Businesses

Table 70. Abbott Product Models, Descriptions and Specifications

Table 71. Abbott Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Abbott Sales Value Proportion by Product in 2024

Table 73. Abbott Sales Value Proportion by Application in 2024

Table 74. Abbott Sales Value Proportion by Geographic Area in 2024

Table 75. Abbott Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

Table 76. Abbott Recent Developments

Table 77. Avanos Medical (coolief) Corporation Information

Table 78. Avanos Medical (coolief) Description and Major Businesses

Table 79. Avanos Medical (coolief) Product Models, Descriptions and Specifications

Table 80. Avanos Medical (coolief) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Avanos Medical (coolief) Sales Value Proportion by Product in 2024

Table 82. Avanos Medical (coolief) Sales Value Proportion by Application in 2024

Table 83. Avanos Medical (coolief) Sales Value Proportion by Geographic Area in 2024

Table 84. Avanos Medical (coolief) Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

Table 85. Avanos Medical (coolief) Recent Developments

Table 86. Cosman Medical Corporation Information

Table 87. Cosman Medical Description and Major Businesses

Table 88. Cosman Medical Product Models, Descriptions and Specifications

Table 89. Cosman Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Cosman Medical Sales Value Proportion by Product in 2024

Table 91. Cosman Medical Sales Value Proportion by Application in 2024

Table 92. Cosman Medical Sales Value Proportion by Geographic Area in 2024

Table 93. Cosman Medical Radiofrequency Ablation for Knee Osteoarthritis (OA) SWOT Analysis

Table 94. Cosman Medical Recent Developments

Table 95. Diros Technology Corporation Information

Table 96. Diros Technology Description and Major Businesses

Table 97. Diros Technology Product Models, Descriptions and Specifications

Table 98. Diros Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Diros Technology Recent Developments

Table 100. Vantage MedTech Corporation Information

Table 101. Vantage MedTech Description and Major Businesses

Table 102. Vantage MedTech Product Models, Descriptions and Specifications

Table 103. Vantage MedTech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Vantage MedTech Recent Developments

Table 105. STARmed America Corporation Information

Table 106. STARmed America Description and Major Businesses

Table 107. STARmed America Product Models, Descriptions and Specifications

Table 108. STARmed America Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. STARmed America Recent Developments

Table 110. Beijing Neo Science Corporation Information

Table 111. Beijing Neo Science Description and Major Businesses

Table 112. Beijing Neo Science Product Models, Descriptions and Specifications

Table 113. Beijing Neo Science Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Beijing Neo Science Recent Developments

Table 115. Key Raw Materials Distribution

Table 116. Raw Materials Key Suppliers

Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 118. Milestones in Production Technology Evolution

Table 119. Distributors List

Table 120. Market Trends and Market Evolution

Table 121. Market Drivers and Opportunities

Table 122. Market Challenges, Risks, and Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Radiofrequency Ablation for Knee Osteoarthritis (OA) Product Picture

Figure 2. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Device Product Picture

Figure 4. Service Product Picture

Figure 5. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Clinic

Figure 8. Radiofrequency Ablation for Knee Osteoarthritis (OA) Report Years Considered

Figure 9. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 10. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 11. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 12. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Market Share by Region (2020-2031)

Figure 13. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales (2020-2031) & (Units)

Figure 14. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales (CAGR) by Region (2020-2031) (Units)

Figure 15. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Market Share by Region (2020-2031)

Figure 16. Top 5 and Top 10 Manufacturers Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume Market Share in 2024

Figure 17. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Market Share Ranking (2024)

Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 19. Device Revenue Market Share by Manufacturer in 2024

Figure 20. Service Revenue Market Share by Manufacturer in 2024

Figure 21. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Market Share by Type (2020-2031)

Figure 22. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Market Share by Type (2020-2031)

Figure 23. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Market Share by Application (2020-2031)

Figure 24. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue Market Share by Application (2020-2031)

Figure 25. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales YoY (2020-2031) & (Units)

Figure 26. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue YoY (2020-2031) & (US$ Million)

Figure 27. North America Top 5 Manufacturers Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) in 2024

Figure 28. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Type (2020- 2031)

Figure 29. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 30. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Application (2020-2031)

Figure 31. North America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 32. US Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 33. Canada Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 34. Mexico Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 35. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales YoY (2020-2031) & (Units)

Figure 36. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue YoY (2020-2031) & (US$ Million)

Figure 37. Europe Top 5 Manufacturers Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) in 2024

Figure 38. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Type (2020-2031)

Figure 39. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 40. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Application (2020-2031)

Figure 41. Europe Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 42. Germany Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 43. France Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 44. U.K. Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 45. Italy Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 46. Russia Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 47. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales YoY (2020-2031) & (Units)

Figure 48. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue YoY (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Top 8 Manufacturers Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) in 2024

Figure 50. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Type (2020- 2031)

Figure 51. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 52. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Application (2020-2031)

Figure 53. Asia-Pacific Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 54. Indonesia Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 55. Japan Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 56. South Korea Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 57. China Taiwan Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 58. India Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2031) & (US$ Million)

Figure 59. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales YoY (2020-2031) & (Units)

Figure 60. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Central and South America Top 5 Manufacturers Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) in 2024

Figure 62. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Type (2021-2031)

Figure 63. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 64. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Application (2020-2031)

Figure 65. Central and South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 66. Brazil Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2025) & (US$ Million)

Figure 67. Argentina Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2025) & (US$ Million)

Figure 68. Middle East, and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales YoY (2020-2031) & (Units)

Figure 69. Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue YoY (2020-2031) & (US$ Million)

Figure 70. Middle East and Africa Top 5 Manufacturers Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) in 2024

Figure 71. Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Type (2021-2031)

Figure 72. South America Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 73. Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Volume (Units) by Application (2020-2031)

Figure 74. Middle East and Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 75. GCC Countries Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2025) & (US$ Million)

Figure 76. Turkey Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2025) & (US$ Million)

Figure 77. Egypt Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2025) & (US$ Million)

Figure 78. South Africa Radiofrequency Ablation for Knee Osteoarthritis (OA) Revenue (2020-2025) & (US$ Million)

Figure 79. Radiofrequency Ablation for Knee Osteoarthritis (OA) Industry Chain Mapping

Figure 80. Regional Radiofrequency Ablation for Knee Osteoarthritis (OA) Manufacturing Base Distribution (%)

Figure 81. Global Radiofrequency Ablation for Knee Osteoarthritis (OA) Production Market Share by Region (2020-2031)

Figure 82. Radiofrequency Ablation for Knee Osteoarthritis (OA) Production Process

Figure 83. Regional Radiofrequency Ablation for Knee Osteoarthritis (OA) Production Cost Structure

Figure 84. Channels of Distribution (Direct Vs Distribution)

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions